Showing results (1341-1350 of 1,385) with videos related to
Sort By:
Pageof 139
Journal of Endourology|May 19, 2010
Focal therapy in prostate cancer-report from a consensus panelJ de la Rosette, H Ahmed, J Barentsz, et al.Neurotoxicology|August 8, 2006
Hershey Medical Center Technical Workshop Report: optimizing the design and interpretation of epidemiologic studies for assessing neurodevelopmental effects from in utero chemical exposureRobert W Amler, Stanley Barone, Aysenil Belger, et al.Leukemia|December 19, 2023
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasmsTracy Murphy, Jacqueline M Mason, Brian Leber, et al.Bioorganic & Medicinal Chemistry Letters|September 6, 2016
Design and optimization of (3-aryl-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-ones as potent PLK4 inhibitors with oral antitumor efficacySze-Wan Li, Yong Liu, Peter B Sampson, et al.Nature Cell Biology|August 11, 2025
A SETD2-CDK1-lamin axis maintains nuclear morphology and genome stabilityAbid Khan, Cheng Zhang, Phu G Nguyen, et al.Elife|April 29, 2024
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibitionGregory Caleb Howard, Jing Wang, Kristie L Rose, et al.Cell Reports|January 9, 2022
SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian displayRoy A Ehling, Cédric R Weber, Derek M Mason, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2016
Discovery of 4-(4-aminopyrazolo[1,5-a][1,3,5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of Tyrosine Threonine Kinase, TTKRadoslaw Laufer, Sze-Wan Li, Yong Liu, et al.Journal of Medicinal Chemistry|July 9, 2013
The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agentsRadoslaw Laufer, Bryan Forrest, Sze-Wan Li, et al.JCI Insight|June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinomaPeter J Siska, Kathryn E Beckermann, Frank M Mason, et al.Pageof 139